[1] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[2] |
JALAN R, GINES P, OLSON JC, et al. Acute-on chronic liver failure[J]. J Hepatol, 2012, 57( 6): 1336- 1348. DOI: 10.1016/j.jhep.2012.06.026.
|
[3] |
YANG LL, LI J. Differences in the diagnostic criteria for acute-on-chronic liver failure between the East and the West[J]. J Clin Hepatol, 2019, 35( 9): 1903- 1908. DOI: 10.3969/j.issn.1001-5256.2019.09.003.
杨玲玲, 李君. 慢加急性肝衰竭诊断标准东西方差异再认识[J]. 临床肝胆病杂志, 2019, 35( 9): 1903- 1908. DOI: 10.3969/j.issn.1001-5256.2019.09.003.
|
[4] |
DONG JL, CHEN Y. Judgement of severity and clinical classification of chronic acute liver failure: Debate and discussion[J]. Chin Hepatol, 2021, 26( 2): 101- 103. DOI: 10.14000/j.cnki.issn.1008-1704.2021.02.001.
董金玲, 陈煜. 慢加急性肝衰竭疾病严重程度判断及临床分型:争鸣与探讨[J]. 肝脏, 2021, 26( 2): 101- 103. DOI: 10.14000/j.cnki.issn.1008-1704.2021.02.001.
|
[5] |
MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144( 7): 1426- 1437. DOI: 10.1053/j.gastro.2013.02.042.
|
[6] |
CHEN Y. Highlight of a new clinical classification of acute-on-chronic liver failure[J]. J Pract Hepatol, 2020, 23( 4): 457- 458. DOI: 10.3969/j.issn.1672-5069.2020.04.001.
陈煜. 再论慢加急性肝衰竭新的临床分型及临床意义[J]. 实用肝脏病杂志, 2020, 23( 4): 457- 458. DOI: 10.3969/j.issn.1672-5069.2020.04.001.
|
[7] |
XU MM, KONG M, CAO YY, et al. A new perspective on acute-on-chronic liver failure based on clinical outcome of dynamic classification criteria[J]. Chin J Hepatol, 2020, 28( 4): 319- 325. DOI: 10.3760/cma.j.cn501113-0309-00099.
徐曼曼, 孔明, 曹影影, 等. 慢加急性肝衰竭分型新视点: 基于临床转归的动态分型新标准[J]. 中华肝脏病杂志, 2020, 28( 4): 319- 325. DOI: 10.3760/cma.j.cn501113-0309-00099.
|
[8] |
WANG XB, GAO FY. Acute-on-chronic liver failure: Difference in definition and prognosis between the East and West[J]. World Chin J Dig, 2017, 25( 21): 1910- 1920. DOI: 10.11569/wcjd.v25.i21.1910.
王宪波, 高方媛. 慢加急性肝衰竭: 东西方诊断和预后的差异[J]. 世界华人消化杂志, 2017, 25( 21): 1910- 1920. DOI: 10.11569/wcjd.v25.i21.1910.
|
[9] |
MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31( 4): 864- 871. DOI: 10.1053/he.2000.5852.
|
[10] |
KIM WR, BIGGINS SW, KREMERS WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med, 2008, 359( 10): 1018- 1026. DOI: 10.1056/nejmoa0801209.
|
[11] |
SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3.
|
[12] |
GOUDSMIT BFJ, PUTTER H, TUSHUIZEN ME, et al. Validation of the Model for End-stage Liver Disease sodium(MELD-Na) score in the Eurotransplant region[J]. Am J Transplant, 2021, 21( 1): 229- 240. DOI: 10.1111/ajt.16142.
|
[13] |
XU MM, WU Y, LI SS, et al. Application of different prognostic scores in liver transplantation decision-making for acute-on-chronic liver failure[J]. Chin J Hepatol, 2023, 31( 6): 574- 581. DOI: 10.3760/cma.j.cn501113-20230202-00031.
徐曼曼, 武羽, 李珊珊, 等. 不同预后评分在慢加急性肝衰竭肝移植决策中的应用[J]. 中华肝脏病杂志, 2023, 31( 6): 574- 581. DOI: 10.3760/cma.j.cn501113-20230202-00031.
|
[14] |
XU MM, YU PF, CHEN Y, et al. Amencan college of gastroenterology clinical guidelines for acute-on-chromc liver failure[J]. Chin J Hepatol, 2022, 30( 2): 199- 203. DOI: 10.3760/cma.j.cn501113-20220126-00047.
徐曼曼, 余朋飞, 陈煜, 等. 美国胃肠病学会《慢加急性肝衰竭临床指南》摘译[J]. 中华肝脏病杂志, 2022, 30( 2): 199- 203. DOI: 10.3760/cma.j.cn501113-20220126-00047.
|
[15] |
SUNDARAM V, SHAH P, MAHMUD N, et al. Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy[J]. Aliment Pharmacol Ther, 2020, 52( 7): 1204- 1213. DOI: 10.1111/apt.15988.
|
[16] |
BURRA P, SAMUEL D, SUNDARAM V, et al. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation[J]. J Hepatol, 2021, 75( Suppl 1): S178-S190. DOI: 10.1016/j.jhep.2021.01.007.
|